Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Stereotactic Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT03158883
What this trial is testing

UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients

Who this might be right for
Metastatic Non-small Cell Lung Cancer (NSCLC)
Megan Daly, MD 8
Testing effectiveness (Phase 2)Study completedNCT02444741
What this trial is testing

Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaStage IV Lung Non-Small Cell Cancer AJCC v7
M.D. Anderson Cancer Center 124
Not applicableUnknownNCT06481566
What this trial is testing

Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial

Who this might be right for
Non-small Cell Lung Cancer
Chongqing University Cancer Hospital 30
Not applicableLooking for participantsNCT05724004
What this trial is testing

Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)

Who this might be right for
Radiotherapy Side EffectNon-small Cell Lung CancerALK Gene Mutation
Karolinska University Hospital 70
Early research (Phase 1)Study completedNCT03535363
What this trial is testing

Osimertinib With Stereotactic Radiosurgery (SRS) in Brain Metastases From EGFR Positive NSCLC

Who this might be right for
NSCLCNon-small Cell Lung Cancer
Case Comprehensive Cancer Center 6
Large-scale testing (Phase 3)Looking for participantsNCT06523673
What this trial is testing

Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Non-Small Cell Lung CancerNSCLC Stage IVOligoProgressive Metastatic Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine 104
Early research (Phase 1)Study completedNCT00946673
What this trial is testing

Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain CancerNeoplasm MetastasisLung Cancer+1 more
Stanford University 17
Not applicableStudy completedNCT02357992
What this trial is testing

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 122
Testing effectiveness (Phase 2)Looking for participantsNCT06121505
What this trial is testing

Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer

Who this might be right for
Lung Squamous Cell Carcinoma
Sichuan University 114
Not applicableStudy completedNCT04912128
What this trial is testing

Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases in NSCLC

Who this might be right for
Stereotactic Body Radiation Therapy
Peking University Third Hospital 30
Not applicableStudy completedNCT00632281
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors

Who this might be right for
Lung Cancer
University of Florida 38
Large-scale testing (Phase 3)Study completedNCT02831959
What this trial is testing

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

Who this might be right for
Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
NovoCure GmbH 298
Testing effectiveness (Phase 2)Active Not RecruitingNCT06020066
What this trial is testing

SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Fudan University 202
Testing effectiveness (Phase 2)WithdrawnNCT04889066
What this trial is testing

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Brain Metastases from Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center
Early research (Phase 1)Active Not RecruitingNCT05615142
What this trial is testing

Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC.

Who this might be right for
NSCLCLow Dose RadiotherapyStereotactic Body Radiotherapy+1 more
Sichuan University 9
Early research (Phase 1)Study completedNCT00328562
What this trial is testing

ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Carcinoma (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 13
Testing effectiveness (Phase 2)Ended earlyNCT02513667
What this trial is testing

Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma

Who this might be right for
ALK-positive Non-small Cell Lung Cancer
University of Texas Southwestern Medical Center 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770100
What this trial is testing

Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)

Who this might be right for
Head and Neck CancerNon-Small Cell Lung CancerCervical Cancer+2 more
Mark Bernard 35
Not applicableStudy completedNCT06236516
What this trial is testing

One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors

Who this might be right for
Lung CancerOligometastatic Lung Tumor
Washington University School of Medicine 10
Early research (Phase 1)Looking for participantsNCT07619599
What this trial is testing

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainOligoprogressive Lung Non-Small Cell Carcinoma+1 more
City of Hope Medical Center 6
Next Page